YK-11 is a synthetic compound classified within the category of selective androgen receptor modulators (SARMs). It is also studied for its interaction with regulatory proteins involved in cellular growth signaling pathways.

In controlled research environments, YK-11 is examined for its structural properties and its ability to interact with intracellular receptors and signaling molecules. Its molecular framework supports investigation into receptor binding dynamics and regulatory pathway modulation.

This compound is supplied strictly for laboratory research purposes and is not intended for consumption, medical, or diagnostic use.

Mechanism of Action

At the molecular level, YK-11 Injectable is studied for its interaction with androgen receptors. Upon binding, it forms a receptor-ligand complex that may influence receptor conformation and downstream transcriptional activity. This interaction is analyzed in vitro to evaluate receptor selectivity and signaling pathway engagement.

In addition, YK-11 is investigated for its interaction with myostatin-related signaling pathways. Myostatin is a regulatory protein associated with cellular growth control. Research focuses on how YK-11 may modulate signaling pathways linked to myostatin activity, including its influence on transcriptional regulators involved in protein expression.

These mechanisms are studied under controlled experimental conditions to better understand receptor-mediated signaling and regulatory pathway dynamics at the biochemical level.

Chemical Properties of YK-11

Research Applications

Androgen Receptor Interaction Studies

YK-11 is utilized in experimental systems to evaluate ligand binding at androgen receptor sites. Researchers analyze receptor affinity, selectivity, and downstream signaling behavior at the molecular level.

Myostatin Pathway Research

This compound is applied in studies investigating regulatory pathways associated with myostatin signaling. These analyses focus on transcriptional regulation and pathway modulation within controlled environments.

Cellular Signaling and Transcription Analysis

YK-11 supports research into intracellular signaling cascades and gene expression mechanisms. Its interaction profile allows for detailed examination of receptor-mediated transcriptional activity.

Why Choose Behemoth Labz to Buy YK-11 for Research

Behemoth Labz provides research-grade YK-11 manufactured under controlled laboratory conditions with strict quality assurance protocols. Each batch undergoes analytical verification to ensure consistency in molecular composition and purity.

Comprehensive documentation, including laboratory testing reports and sourcing transparency, supports reproducibility in experimental settings. BehemothLabz maintains a compliance-focused approach, supplying compounds intended strictly for laboratory-based investigation and analytical research

Disclaimer

YK-11 is intended strictly for laboratory research and analytical purposes only. It is not intended for use in diagnostic procedures, therapeutic applications, or in vivo studies of any kind.

Any references to biochemical pathways, receptor interactions, or enzymatic processes are provided solely for informational and research-context purposes. This compound must be handled exclusively by qualified professionals in controlled laboratory environments in accordance with applicable regulations and safety guidelines.

Improper handling or use outside of controlled research settings is strictly prohibited.

References

• Harding, C., Viljanto, M., Habershon-Butcher, J., Taylor, P., & Scarth, J. (2023). Equine metabolism of the selective androgen receptor modulator YK-11 in urine and plasma following oral administration. Drug testing and analysis, 15(4), 388–407. https://doi.org/10.1002/dta.3425
• Thevis, M., Piper, T., Dib, J., Lagojda, A., Kühne, D., Packschies, L., Geyer, H., & Schänzer, W. (2017). Mass spectrometric characterization of the selective androgen receptor modulator (SARM) YK-11 for doping control purposes. Rapid communications in mass spectrometry : RCM, 31(14), 1175–1183. https://doi.org/10.1002/rcm.7886